Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4808361 | 0.89 | CYP3A4 (0.44) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL4811497 | 0.84 | CYP3A4 (0.43) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL4808035 | 0.82 | CYP3A4 (0.44) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL906667 | 0.76 | CYP3A4 (0.46) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL9716520 | 0.75 | DNM1 (0.41) | CYP3A4ALDH1A1TSHRDNM1MEN1 | |
| SCHEMBL18660483 | 0.73 | ALDH1A1 (0.38) | CYP3A4ALDH1A1TDP1 | |
| SCHEMBL16596400 | 0.72 | ALDH1A1 (0.68) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL8320021 | 0.72 | ALDH1A1 (0.68) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL7617988 | 0.72 | ALDH1A1 (0.52) | CYP3A4ALDH1A1TDP1L3MBTL1TSHR | |
| SCHEMBL3686619 | 0.72 | ATM (0.33) | ADRB2ADRB1ADRB3ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545809-B2 | Moisture-curing conformal coating compositions | WACKER CHEMIE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4172246-B1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-20230279263-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2023-09-07 | — | — | US | disclosed |
| EP-4172246-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | Wacker Chemie AG (DE) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021259460-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-12-30 | — | — | WO | disclosed |
| EP-0197540-B1 | USE OF AMINES FOR STABILIZING POLYSILOXANE FLUIDS | WACKER-CHEMIE GMBH (DE) | 1991-11-13 | — | — | EP | disclosed |
| US-4933414-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1990-06-12 | — | — | US | disclosed |
| US-4783490-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| US-4644074-A | AGAINST DEGRADATION BY KAOLIN CLAY BY ADDING AN AMINE | SWS SILICONES CORPORATION (US) | 1987-02-17 | — | — | US | disclosed |
| EP-0197540-A2 | Use of amines for stabilizing polysiloxane fluids | WACKER-CHEMIE GMBH (DE) | 1986-10-15 | — | — | EP | disclosed |
| US-4612055-A | Stabilized blends of thiofunctional polysiloxane fluids and organopolysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-09-16 | — | — | US | disclosed |
| US-4588771-A | Stabilized thiofunctional polysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545809-B2 | Moisture-curing conformal coating compositions | COL1A1, COL2A1, MSR1 | CYP3A4 2387/4885ALDH1A1 308/4885TDP1 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.